Plasma adiponectin distribution in a Mediterranean population and its association with cardiovascular risk factors and metabolic syndrome - PubMed (original) (raw)
Plasma adiponectin distribution in a Mediterranean population and its association with cardiovascular risk factors and metabolic syndrome
Jordi Salas-Salvadó et al. Metabolism. 2007 Nov.
Abstract
Adiponectin may play an important role in the regulation of body weight, insulin resistance, and cardiovascular disease. The aim of this study was to evaluate the distribution of adiponectin in a Mediterranean adult population and its relationship with cardiovascular risk factors and metabolic syndrome. A cross-sectional study was performed in a representative sample of 1023 subjects from a Spanish Mediterranean population. Individuals with the metabolic syndrome were identified using the diagnostic criteria of the Adult Treatment Panel III. Anthropometric parameters were measured, and biochemical analyses were performed in fasting conditions. Plasma insulin levels were measured and homeostasis model assessment of insulin resistance was calculated. Plasma adiponectin levels were measured by a commercial radioimmunoassay. Median levels of adiponectin were significantly higher in women than in men after adjusting for differences in body mass index. However, no differences in adiponectin plasma levels were observed in relation to age. Significantly lower levels of adiponectin were also observed in women with obesity, abdominal obesity, hyperglycemia or diabetes, low high-density lipoprotein cholesterol, hypertriglyceridemia, or metabolic syndrome. In men, only those with obesity, abdominal obesity, low high-density lipoprotein cholesterol, hypertriglyceridemia, or metabolic syndrome showed significantly lower plasma levels of adiponectin. In a stepwise multivariate analysis, sex, waist circumference, serum C-reactive protein serum levels, and homeostasis model assessment of insulin resistance explained 23.4% of its variability. In conclusion, adiponectin plasma levels are more closely related to the components of the metabolic syndrome in women than in men in a Mediterranean population.
Similar articles
- Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.
Patel DA, Srinivasan SR, Xu JH, Chen W, Berenson GS. Patel DA, et al. Metabolism. 2006 Nov;55(11):1551-7. doi: 10.1016/j.metabol.2006.06.028. Metabolism. 2006. PMID: 17046560 - Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
Mojiminiyi OA, Abdella NA, Al Arouj M, Ben Nakhi A. Mojiminiyi OA, et al. Int J Obes (Lond). 2007 Feb;31(2):213-20. doi: 10.1038/sj.ijo.0803355. Epub 2006 Jun 6. Int J Obes (Lond). 2007. PMID: 16755284 - Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J, McQuillan BM, Thompson PL, Beilby JP. Hung J, et al. Int J Obes (Lond). 2008 May;32(5):772-9. doi: 10.1038/sj.ijo.0803793. Epub 2008 Feb 5. Int J Obes (Lond). 2008. PMID: 18253163 - Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome?
Brooks NL, Moore KS, Clark RD, Perfetti MT, Trent CM, Combs TP. Brooks NL, et al. Diabetes Obes Metab. 2007 May;9(3):246-58. doi: 10.1111/j.1463-1326.2006.00596.x. Diabetes Obes Metab. 2007. PMID: 17391150 Review. - Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.
Vona-Davis L, Howard-McNatt M, Rose DP. Vona-Davis L, et al. Obes Rev. 2007 Sep;8(5):395-408. doi: 10.1111/j.1467-789X.2007.00396.x. Obes Rev. 2007. PMID: 17716297 Review.
Cited by
- Relations of Visceral and Abdominal Subcutaneous Adipose Tissue, Body Mass Index, and Waist Circumference to Serum Concentrations of Parameters of Chronic Inflammation.
Schlecht I, Fischer B, Behrens G, Leitzmann MF. Schlecht I, et al. Obes Facts. 2016;9(3):144-57. doi: 10.1159/000443691. Epub 2016 Jun 1. Obes Facts. 2016. PMID: 27241125 Free PMC article. - Adiponectin and metabolic syndrome in a Tunisian population.
Ben Ali S, Jemaa R, Ftouhi B, Kallel A, Feki M, Slimene H, Kaabachi N. Ben Ali S, et al. Inflammation. 2012 Jun;35(3):828-33. doi: 10.1007/s10753-011-9383-8. Inflammation. 2012. PMID: 21912966 - A randomized trial of selenium supplementation and risk of type-2 diabetes, as assessed by plasma adiponectin.
Rayman MP, Blundell-Pound G, Pastor-Barriuso R, Guallar E, Steinbrenner H, Stranges S. Rayman MP, et al. PLoS One. 2012;7(9):e45269. doi: 10.1371/journal.pone.0045269. Epub 2012 Sep 19. PLoS One. 2012. PMID: 23028897 Free PMC article. Clinical Trial. - Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver.
Goossens GH, Jocken JWE, Blaak EE. Goossens GH, et al. Nat Rev Endocrinol. 2021 Jan;17(1):47-66. doi: 10.1038/s41574-020-00431-8. Epub 2020 Nov 10. Nat Rev Endocrinol. 2021. PMID: 33173188 Review. - Diagnosis and management of peripheral artery disease in women.
Walker JP, Hiramoto JS. Walker JP, et al. Int J Womens Health. 2012;4:625-34. doi: 10.2147/IJWH.S31073. Epub 2012 Dec 14. Int J Womens Health. 2012. PMID: 23277744 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials